Chinese Mainland: U.S. Fentanyl Tariffs Undermine Anti-Drug Cooperation
The Chinese mainland warns that U.S. ‘fentanyl tariffs’ could derail bilateral drug-control efforts, calling for dialogue based on equality, respect and mutual benefit.
DrugControl
Read More
Chinese Mainland Expands Drug Control List with Nitazenes and 12 New Substances
The Chinese mainland has added nitazenes and 12 psychoactive substances to its controlled drug list, stepping up measures against synthetic opioids amid evolving global narcotics challenges.
China Unveils Comprehensive White Paper on Fentanyl Control
China’s State Council Information Office releases a white paper detailing the “1+5+N” narcotics laboratory network, reinforcing its global stance on fentanyl control.
China Slams U.S. 10% Tariffs on Imports Over Fentanyl Policies
China’s Public Security Ministry strongly opposes U.S. 10% tariffs on imports, citing rigorous drug control policies and highlighting the importance of bilateral cooperation.
China and U.S. Boost Cooperation to Tackle Fentanyl Crisis
China and the U.S. enhance counternarcotics efforts to tackle the fentanyl crisis amidst ongoing challenges and political tensions.
China Urges U.S. to Preserve Drug-Control Cooperation Amid Trade Tensions
China urges the U.S. to maintain strong drug-control cooperation amidst trade tensions, emphasizing their joint effort in combating fentanyl.
China and U.S. Expand Drug Control Cooperation
China and the U.S. agree to deepen law enforcement cooperation on drug control during the 10th strategic intelligence sharing conference in Shanghai.
Why China Isn’t the Source of America’s Opioid Crisis
Amid U.S. claims about fentanyl origins, China’s strict opioid regulations and domestic factors challenge simplistic narratives about the crisis.